Conversely, the levels of adiponectin, which is typically regarded as protective against bone loss, are often diminished in obesity, potentially facilitating increased osteoclastogenesis, as reduced levels of adiponectin correlate with enhanced bone resorption [19,20,21]. The gene discussed is ADIPOQ; the disease is obesity disorder.